Journals / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 2

The Predictive Ability of the C-reactive Protein to Albumin Ratio As A Mortality Predictor in Hospitalized Severe SARS-CoV-2 Infected Patients with Cardiovascular Diseases

Pages
152–160
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Deceased patients had significantly more frequent CVD (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Although there are few studies on the predictive value of C-reactive protein-to-albumin ratio (CAR) in coronavirus disease-2019 (COVID-19) patients, to the best of our knowledge, there are no studies specifically conducted in COVID-19 patients with cardiovascular disease (CVD).
📊
Key Findings & Data:This study assessed the use of baseline CAR levels to predict death in hospitalized COVID-19 patients with CVD.
💡
Conclusion & Impact:Deceased patients had significantly more frequent CVD (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Although there are few studies on the predictive value of C-reactive protein-to-albumin ratio (CAR) in coronavirus disease-2019 (COVID-19) patients, to the best of our knowledge, there are no studies specifically conducted in COVID-19 patients with cardiovascular disease (CVD). This study assessed the use of baseline CAR levels to predict death in hospitalized COVID-19 patients with CVD. Methods: This study was designed as a single-center cross-sectional study. Patients diagnosed with COVID-19 who were admitted to the University of Health Sciences Turkey, Bagcilar Training and Research Hospital between April 16 and May 20, 2020 were analyzed retrospectively. The patients were divided into 2 groups: those who died and those who survived, considering the follow-up period. The CAR values of the study population, as well as patients with CVD, were calculated, and the association of CAR with in-hospital mortality was evaluated. Results: The in-hospital mortality rate was 11.1% (49/442 pts) in all populations. Deceased patients had significantly more frequent CVD (p

🔖

Cite This Article

Katkat, F., Karabulut, U., Karahan, S., Okuyan, E., Kalyoncuoglu, M., Ozcan, S., Tasdem, Z. A., Kucuk, S. H., Guner, A., Biter, H. I., Cağlar, F. N. T. (2022). The Predictive Ability of the C-reactive Protein to Albumin Ratio As A Mortality Predictor in Hospitalized Severe SARS-CoV-2 Infected Patients with Cardiovascular Diseases. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 2, 152–160. https://ajindex.com/articles/534927

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Life Sci 2020;254:117788
  2. World Health Organization. Naming the Coronavirus Disease (COVID-2019) and the Virus That Causes It. 2020. Available online: https://www.who.int/emergencies/diseases/novel- coronavirus-2019/technical-guidance/naming-the- coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (accessed on 11 March 2020)
  3. Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020;81:e6–e12
  4. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020;20:669-77
  5. Bayrak M. Predictive value of C-Reactive Protein/Albumin ratio in patients with chronic complicated diabetes mellitus. Pak J Med Sci 2019;35:1616-21
  6. Yazar T, Yazar HO. Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease. Turk J Neurol 2019;25:123-8
  7. Taheri S, Baradaran A, Aliakbarian M, Mortazavi M. Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease. J Res Med Sci 2017;22:47
  8. Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: A retrospective analysis. Sci Rep 2018;8:14977
  9. Haruki K, Shiba H, Shirai Y, et al. The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection. World J Surg 2016;40:2254- 60
  10. Moon JS, Ahn SS, Park YB, Lee SK, Lee SW. C-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All- Cause Mortality in Patients with ANCA-Associated Vasculitis. Yonsei Med J 2018;59:865-71
  11. Liu ZY, Tang JN, Cheng MD, et al. C-reactive protein-to-serum albumin ratio as a novel predictor of long-term outcomes in coronary artery disease patients who have undergone percutaneous coronary intervention: analysis of a real-world retrospective cohort study. Coron Artery Dis 2021;32:191-6
  12. Kelesoglu S, Yilmaz Y, Elcık D. Relationship Between C-Reactive Protein to Albumin Ratio and Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease. Angiology 2021;72:829-35
  13. Lucijanić M, Stojić J, Atić A, et al. Clinical and prognostic significance of C-reactive pr